Fri news: AbbVie buying Roche spinout Nimble. UK private market prefers Mounjaro vs Wegovy. ICER finds more ‘unsupported’ drug price hikes. Beigene’s $150M cancer deal. Editas layoffs. —http://bit.ly/w28kSd
Cafepharma
Cafepharma is a site for the pharmaceutical/medical industry. Our scope includes pharmaceutical, device, biotech, laboratory, animal health, dental, etc. We have curated daily news headlines, active forums where users can post anonymously, job listings and more.